SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038046
Filing Date
2024-03-28
Accepted
2024-03-28 16:11:23
Documents
93
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scyx-20231231.htm   iXBRL 10-K 2800655
2 EX-10.21 scyx-ex10_21.htm EX-10.21 10179
3 EX-10.41 scyx-ex10_41.htm EX-10.41 156196
4 EX-23.1 scyx-ex23_1.htm EX-23.1 8556
5 EX-31.1 scyx-ex31_1.htm EX-31.1 13253
6 EX-31.2 scyx-ex31_2.htm EX-31.2 13217
7 EX-32.1 scyx-ex32_1.htm EX-32.1 11000
8 EX-97.1 scyx-ex97_1.htm EX-97.1 53912
  Complete submission text file 0000950170-24-038046.txt   12913651

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20231231.xsd EX-101.SCH 1911166
97 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20231231_htm.xml XML 2324062
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36365 | Film No.: 24799020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)